Hospital Acquired Infection Control Market, By Product (Sterilant, Disinfectants, and Other Products), By Indication (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections, and Other Indications), By End User (Hospitals & Intensive Care Units, Ambulatory Surgical & Diagnostic Centers, and Nursing Homes & Maternity Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI377019 | Publish Date: August 2023 | No. of Pages: 165

Global Hospital Acquired Infection Control Overview

Introduction:

Hospital Acquired Infection Control is also called as nosocomial infection acquired in a medical setting in the course of medical treatment. The hospital acquired infection meets the criteria such as hospital acquired infection was incubating at the admission but related to a pervious procedure or the admission to different or same health- care facility. The criterion is temporarily associated with admission or procedure at a health- care facility. Hospital acquired infection cannot found on the admission of patient in the hospitals. The HAI can occur after 48 hours when admitted in hospital.

Global Hospital Acquired Infection Control Dynamics

Rise in hospital stay due to chronic disease and surgeries are the major propelling factor for the growth of target market. Additionally, increase in the incidences of the different types of the hospitals acquired infections is the driving factor for the growth of the global hospital acquired infection control market. In 2018, according to the Tehran University of Medical Sciences, the prevalence of hospital-acquired infection (HAI) was around 30.43%. Moreover, innovation technologies implemented in devices that control infection is the boosting factor for the growth of target market. However, lack of awareness regarding to the hospitals acquired infections and hygiene standards is the major restraining factor for the growth of global market. In addition, the stringent regulatory requirements which is the hampering factor for the growth of target market. Nevertheless, the increasing awareness and adopting government policies about controlling hospital acquired infection can create lucrative opportunity for the growth of target market.  

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Hospital Acquired Infection Control Segmentation

The global hospital acquired infection control market is segmented based on product, indication, end user, and region.

On the basis of product, the global hospital acquired infection control market is segmented into sterilant, disinfectants, and other products. Other product segment is dominating the global market and is expected to maintain its dominance over the forecast period. On the basis of indication, the target market is segmented into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and other indications. The hospital acquired pneumonia indication segment is dominating the global market due to rise in number of patients of HAP. Based on end user, the global market is classified into hospitals & intensive care units, ambulatory surgical & diagnostic centers, and nursing homes & maternity centers.

Regional Insights:

Based on region the global hospital acquired infection control market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The global market in North America region is seen to have a matured growth since this market is showing largest market share over the forecast period due to better adaptation, better healthcare facilities and higher rate of hygiene practices. North America accounts for large scale hospital acquired infection control market share. Asia- Pacific region hospital acquired infection control market is expected to witness fast growth due to rise in adaptation of hospital acquired infection control practice during the forecast period.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Global Hospital Acquired Infection Control Market, By Product:

  • Sterilant
  • Disinfectants
  • Other Products

Global Hospital Acquired Infection Control Market, By Indication:

  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections
  • Other Indications

Global Hospital Acquired Infection Control Market, By End User:

  • Hospitals & Intensive Care Units
  • Ambulatory Surgical & Diagnostic Centers
  • Nursing Homes & Maternity Centers

Global Hospital Acquired Infection Control Market, By Region:

  • North America
        • North America Hospital Acquired Infection Control Market, By Product
        • North America Hospital Acquired Infection Control Market, By Indication
        • North America Hospital Acquired Infection Control Market, By End User
        • North America Hospital Acquired Infection Control Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe Hospital Acquired Infection Control Market, By Product
        • Europe Hospital Acquired Infection Control Market, By Indication
        • Europe Hospital Acquired Infection Control Market, By End User
        • Europe Hospital Acquired Infection Control Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Hospital Acquired Infection Control Market, By Product
        • Asia Pacific Hospital Acquired Infection Control Market, By Indication
        • Asia Pacific Hospital Acquired Infection Control Market, By End User
        • Asia Pacific Hospital Acquired Infection Control Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • RestofAsia Pacific                                                                                                                                                                                                
      • Latin America
        • Latin America Hospital Acquired Infection Control Market, By Product
        • Latin America Hospital Acquired Infection Control Market, By Indication
        • Latin America Hospital Acquired Infection Control Market, By End User
        • Latin America Hospital Acquired Infection Control Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Hospital Acquired Infection Control Market, By Product
        • Middle East & Africa Hospital Acquired Infection Control Market, By Indication
        • Middle East & Africa Hospital Acquired Infection Control Market, By End User
        • Middle East & Africa Hospital Acquired Infection Control Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Hospital Acquired Infection Control Key Players

The key players operating the global hospital acquired infection control market involves 3M Company, Becton Dickinson and Company, Fortive Corporation, Metall Zug Group (Belimed), Cantel Medical, Getinge AB, Sotera Health, STERIS PLC., S. C. Johnson & Son Inc., and Tuttnauer. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.

Global Hospital Acquired Infection Control Company Profile

  • 3M Company *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Becton Dickinson and Company
  • Fortive Corporation
  • Metall Zug Group (Belimed)
  • Cantel Medical
  • Getinge AB
  • Sotera Health
  • STERIS PLC.
  • S. C. Johnson & Son Inc.
  • Tuttnauer

“*” marked represents similar segmentation in other categories in the respective section

Global Hospital Acquired Infection Control Table of Contents

 

Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Indication
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  4. Global Hospital Acquired Infection Control Market, By Product, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Sterilant
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Disinfectants
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Other Product
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  5. Global Hospital Acquired Infection Control Market, By Indication, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Hospital Acquired Pneumonia
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Bloodstream Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Surgical Site Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Gastrointestinal Infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Urinary Tract infections
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Other Indications
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  6. Global Hospital Acquired Infection Control Market, By End User, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Hospitals & Intensive Care Units
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Ambulatory Surgical & Diagnostic Centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Nursing Homes & Maternity Centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  7. Global Hospital Acquired Infection Control Market, By Region, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Indication, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By End User, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
      • 3M Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Becton Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Fortive Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Metall Zug Group (Belimed)
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Cantel Medical
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Getinge AB
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Sotera Health
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • STERIS PLC.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • S. C. Johnson & Son Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Tuttnauer
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  10. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The global hospital acquired infection control market is segmented based on product, indication, end user, and region.

Rise in hospital stay due to chronic disease and surgeries are the major propelling factor for the growth of target market. Additionally, increase in the incidences of the different types of the hospitals acquired infections is the driving factor for the growth of the global hospital acquired infection control market.

Based on region the global hospital acquired infection control market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global market in North America region is seen to have a matured growth since this market is showing largest market share over the forecast period due to better adaptation, better healthcare facilities and higher rate of hygiene practices.

The key players operating the global hospital acquired infection control market involves 3M Company, Becton Dickinson and Company, Fortive Corporation, Metall Zug Group (Belimed), Cantel Medical, Getinge AB, Sotera Health, STERIS PLC., S. C. Johnson & Son Inc., and Tuttnauer. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.